{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:38:48Z","timestamp":1794281928564,"version":"4.9.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2023-I2M-2-005"],"award-info":[{"award-number":["2023-I2M-2-005"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-1-005"],"award-info":[{"award-number":["2021-I2M-1-005"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["T-B-035"],"award-info":[{"award-number":["T-B-035"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2024YFC2510300"],"award-info":[{"award-number":["2024YFC2510300"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC2504603"],"award-info":[{"award-number":["2022YFC2504603"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["2022-PUMCH-D-009"],"award-info":[{"award-number":["2022-PUMCH-D-009"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["2022-PUMCH-A-107"],"award-info":[{"award-number":["2022-PUMCH-A-107"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jaad.2025.06.062","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T12:28:38Z","timestamp":1752582518000},"page":"1422-1431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Prospective Registry Of MyositIS (PROMIS): II. Temporal shifts in causes of death among patients with idiopathic inflammatory myopathies"],"prefix":"10.1016","volume":"93","author":[{"given":"Chen","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangyi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mucong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2025.06.062_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2478\/rir-2024-0018","article-title":"MIP-C: a new autoimmune rheumatic disease concomitant with the COVID-19 pandemic","volume":"5","author":"Brion","year":"2024","journal-title":"Rheumatol Immunol Res"},{"key":"10.1016\/j.jaad.2025.06.062_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105136","article-title":"MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)","volume":"104","author":"David","year":"2024","journal-title":"eBioMedicine"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.062_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41584-023-01033-0","article-title":"Epidemiology of the idiopathic inflammatory myopathies","volume":"19","author":"Khoo","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.062_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/1744666X.2019.1699059","article-title":"Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositis","volume":"16","author":"Gono","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.062_bib5","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jaad.2025.06.062_bib6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.24993","article-title":"Long-term outcomes and prognosis factors in patients with idiopathic inflammatory myopathies based on myositis-specific autoantibodies: a single cohort study","volume":"75","author":"Jiang","year":"2022","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.062_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.semarthrit.2019.12.001","article-title":"Performance of the new EULAR\/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort","volume":"50","author":"Barsotti","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.062_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","article-title":"The EuroMyositis registry: an international collaborative tool to facilitate myositis research","volume":"77","author":"Lilleker","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.062_bib9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/09546634.2017.1403549","article-title":"Recent developments on treatment strategies and the prognosis of dermatomyositis: a review","volume":"29","author":"Isak","year":"2018","journal-title":"J Dermatol Treat"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.062_bib10","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s10067-019-04910-w","article-title":"Mortality of Chinese patients with polymyositis and dermatomyositis","volume":"39","author":"Yang","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.062_bib11","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.semarthrit.2020.08.009","article-title":"Mortality trends in polymyositis and dermatomyositis: a general population-based study","volume":"50","author":"Li","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.062_bib12","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10067-015-3003-1","article-title":"CRDC: a Chinese rheumatology research platform","volume":"34","author":"Li","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.062_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.062_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.062_bib15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1067\/mjd.2002.120621","article-title":"Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?","volume":"46","author":"Sontheimer","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.062_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/rheumatology\/ken441","article-title":"Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis","volume":"48","author":"Harris-Love","year":"2009","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.062_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.10924","article-title":"Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence","volume":"49","author":"Bode","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.062_bib18","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/bjd.18600","article-title":"Outcome measures in dermatomyositis: quality of life and the patient perspective","volume":"182","author":"Nicholson","year":"2020","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.062_bib19","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1002\/art.24904","article-title":"Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index","volume":"60","author":"Rider","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"10015","key":"10.1016\/j.jaad.2025.06.062_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(15)00551-6","article-title":"Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013","volume":"387","author":"Zhou","year":"2016","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.062_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2471\/BLT.15.153148","article-title":"An integrated national mortality surveillance system for death registration and mortality surveillance, China","volume":"94","author":"Liu","year":"2016","journal-title":"Bull World Health Organ"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.062_bib22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.062_bib23","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.30277","article-title":"Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China","volume":"63","author":"Mok","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.062_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","article-title":"Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study","volume":"77","author":"Dobloug","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.062_bib25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.semarthrit.2015.06.005","article-title":"Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort","volume":"45","author":"Dobloug","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.062_bib26","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3899\/jrheum.101002","article-title":"Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan","volume":"38","author":"Yamasaki","year":"2011","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.062_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/08916930600622603","article-title":"Survival, mortality and causes of death in inflammatory myopathies","volume":"39","author":"Torres","year":"2006","journal-title":"Autoimmunity"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.062_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00002281-200109000-00002","article-title":"Mortality and causes of death in systemic lupus erythematosus","volume":"13","author":"Trager","year":"2001","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.062_bib29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00296-021-04897-1","article-title":"Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study","volume":"42","author":"Dunga","year":"2022","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.062_bib30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/acr.22728","article-title":"Anti-Melanoma differentiation-associated gene 5 is associated with rapidly progressive lung disease and poor survival in US patients with amyopathic and myopathic dermatomyositis","volume":"68","author":"Moghadam-Kia","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.062_bib31","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/rheumatology\/ker518","article-title":"The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM","volume":"51","author":"Koga","year":"2012","journal-title":"Rheumatol Oxf Engl"},{"issue":"9","key":"10.1016\/j.jaad.2025.06.062_bib32","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","article-title":"Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis","volume":"51","author":"Gono","year":"2012","journal-title":"Rheumatol Oxf Engl"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.062_bib33","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/art.41105","volume":"72","author":"Tsuji","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.062_bib34","first-page":"803","article-title":"Clinical features of thirty-two patients with anti-melanoma differentiation-associated gene 5 antibodies","volume":"37","author":"Huang","year":"2019","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.062_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.55563\/clinexprheumatol\/df2oc3","article-title":"Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses","volume":"40","author":"Yang","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.062_bib36","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/rheumatology\/keac450","article-title":"Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in China","volume":"62","author":"You","year":"2023","journal-title":"Rheumatol Oxf Engl"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.062_bib37","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/key357","article-title":"The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis","volume":"58","author":"Oldroyd","year":"2019","journal-title":"Rheumatol Oxf Engl"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.062_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120313","article-title":"Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis\/dermatomyositis-associated interstitial lung disease: a retrospective case control study","volume":"10","author":"Hozumi","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.062_bib39","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/joim.13607","article-title":"Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis","volume":"293","author":"Jin","year":"2023","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.062_bib40","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","article-title":"A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies","volume":"56","author":"Pinal-Fernandez","year":"2017","journal-title":"Rheumatol Oxf Engl"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.062_bib41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12016-021-08911-z","article-title":"Anti-Ro52 autoantibody is common in systemic autoimmune rheumatic diseases and correlating with worse outcome when associated with interstitial lung disease in systemic sclerosis and autoimmune myositis","volume":"63","author":"Chan","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.062_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.55563\/clinexprheumatol\/bjb2gf","article-title":"Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study","volume":"40 Suppl 134","author":"Bozzalla-Cassione","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.062_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3899\/jrheum.220139","article-title":"Coexistence of anti-ro52 antibodies in anti-MDA5 antibody-positive dermatomyositis is highly associated with rapidly progressive interstitial lung disease and mortality risk","volume":"50","author":"Lv","year":"2022","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.062_bib44","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1093\/rheumatology\/keac090","article-title":"Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease","volume":"61","author":"Gui","year":"2022","journal-title":"Rheumatol Oxf Engl"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.062_bib45","first-page":"373","article-title":"A systematic review and metaanalysis of predictors of mortality in idiopathic inflammatory myopathy-associated interstitial lung disease","volume":"50","author":"Hannah","year":"2023","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.062_bib46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop:: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.jaad.2025.06.062_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.670784","article-title":"The clinicopathological distinction between seropositive and seronegative immune-mediated necrotizing myopathy in China","volume":"12","author":"Ma","year":"2021","journal-title":"Front Neurol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225023990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225023990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:25:18Z","timestamp":1791879918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225023990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0190962225023990"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.062","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Prospective Registry Of MyositIS (PROMIS): II. Temporal shifts in causes of death among patients with idiopathic inflammatory myopathies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}